AMPH - Amphastar P
Amphastar P Logo

AMPH - Amphastar P

https://www.amphastar.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.

52W High
$53.95
52W Low
$20.39

MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.80
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
11.02
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
7.22
EV/Revenue (<3 favorable)
2.48
P/S (TTM) (<3 favorable)
1.89
P/B (<3 favorable)
1.81
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
24.02%
Institutions (25–75% balanced)
71.85%
Shares Outstanding
46,495,100
Float
35,345,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
722,679,000
Gross Profit (TTM)
360,330,000
EPS (TTM)
2.67
Profit Margin (>10% good)
0.19%
Operating Margin (TTM) (higher better)
0.24%
ROE (TTM) (>15% strong)
0.18%
EPS YoY (Quarterly) (>10% good)
-0.12
Revenue YoY (Quarterly) (>8% good)
-0.04
Momentum
Bearish momentum
Value
0.6997
Previous
0.8920
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025